سعر ازيثرو كيديا 1% قطرة عين 15*0.4 مل وحدات مفردة 2025

Azithrochidia: azithromycin 1% eye drops, 15 single-dose units of 0.4 ml; ophthalmic macrolide antibacterial. Company: Orchidia.

• Bacterial conjunctivitis caused by susceptible isolates of CDC coryneform group G, Haemophilus influenzae, Staphylococcus aureus, Streptococcus mitis group or Streptococcus pneumoniae.Population: Adults and pediatric patientsDailyMed (U.S. National Library of Medicine)

• Most frequently reported ocular adverse reaction: eye irritation (about 1-2% of patients). Reactions in less than 1% included blurred vision, burning/stinging/irritation on instillation, contact dermatitis, corneal erosion, dry eye, dysgeusia, nasal congestion, ocular discharge, punctate keratitis and sinusitis.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Hypersensitivity to any component of the product.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Topical ophthalmic use only; not for systemic administration or injection.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Serious allergic reactions including angioedema, anaphylaxis and dermatologic reactions (Stevens-Johnson syndrome, toxic epidermal necrolysis) have been reported rarely with systemic azithromycin; the potential for such reactions with ophthalmic use is unknown. Discontinue if an allergic reaction occurs.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Prolonged use may result in overgrowth of non-susceptible organisms, including fungi; if superinfection occurs, discontinue and institute alternative therapy.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Available data over several decades with azithromycin use in pregnant women have not identified any drug-associated risk for major birth defects, miscarriage or adverse maternal or fetal outcomes; animal studies showed no fetal malformations at doses orders of magnitude above the exposure possible after topical ocular use.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Azithromycin is present in human milk and non-serious adverse reactions have been reported in breastfed infants after maternal oral use; consider the benefits of breastfeeding with the mother's clinical need for the eye drops (systemic exposure after ocular use is low).International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Azithromycin: Macrolide antibacterial that binds the 23S rRNA of the bacterial 50S ribosomal subunit and inhibits bacterial protein synthesis.